Fact CheckerSign in

NCT06663020Completed

Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery

Source: ClinicalTrials.gov · Last updated 24 Jul 2026

Brief summary (registry, in English)

This study aims to investigate the relationship between the duration of smoking cessation before surgery and postoperative complications in lung cancer patients undergoing surgery. Lung cancer surgery patients who have recently quit smoking or are long-term nonsmokers will be evaluated to determine if the timing of smoking cessation impacts the risk of complications after surgery. By analyzing these factors, the study seeks to provide guidance on optimal smoking cessation timing to reduce postoperative risks.

Status (registry)
Completed
Study type
Observational
Enrollment
156 (actual)
First submitted
27 Oct 2024
Start date
15 Jun 2023
Primary completion date
15 Nov 2024
Lead sponsor
Caner İşevi, MD
Diseases
Lung cancer
NCT number
NCT06663020

What you commit to

  • Study type: Observational
  • Participants enrolled: 156
  • From 15 Jun 2023 to the primary completion date, 15 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients undergoing emergency surgery.
  • Patients who have previously undergone video-assisted thoracoscopic surgery (VATS) and/or thoracotomy.

Other illness

  • Patients with advanced chronic obstructive pulmonary disease (COPD) classified as GOLD Grade III-IV.
  • Patients with severe neuromuscular diseases or advanced thoracic deformity.
  • Patients with severe heart disease classified as New York Heart Association (NYHA) Class III-IV.

Other

  • Patients with severe and uncontrolled bronchial asthma.
  • Patients with cognitive impairments.
  • Pregnant patients.
  • Patients with coagulopathy.
  • Patients who died perioperatively.
  • Patients or their legally authorized representatives who did not provide informed consent.

Who the study is looking for

  • Patients aged between 18 and 80 years.
  • Patients scheduled for elective surgery under general anesthesia due to NSCL.
  • Patients classified as American Society of Anesthesiologists (ASA) I-III.
  • Patients or their legally authorized representatives who have provided informed consent.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ondokuz Mayis University Medical Faculty, Department of Thoracic Surgery
Coordinator of this site? Confirm its status
SamsunTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.